Search results for "Insomnia"
Considerations about cannabis
As more states legalize recreational and medical cannabis, hospital physicians are finding themselves caring for regular users more frequently.
https://immattersacp.org/archives/2024/05/considerations-about-cannabis.htm
1 May 2024
Everyday symptoms could point to potential PTSD
A clinical practice guideline can help clinicians screen for, diagnose, and treat post-traumatic stress disorder (PTSD) and a related condition, acute stress disorder.
https://immattersacp.org/archives/2024/05/everyday-symptoms-could-point-to-potential-ptsd.htm
1 May 2024
Insomnia symptoms, short sleep duration in midlife women linked to CVD risk
Persistent insomnia symptoms, alone and combined with short sleep duration, in women ages 42 to 52 years were associated with a subsequent 70% to 75% increased risk of cardiovascular disease (CVD).
https://immattersacp.org/weekly/archives/2024/02/06/2.htm
6 Feb 2024
MKSAP Quiz: 1-year history of insomnia
An 87-year-old woman is evaluated for a 1-year history of bothersome insomnia. She reports taking up to 2 hours to fall asleep. She also feels that her sleep is less refreshing. What is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2023/11/21/3.htm
21 Nov 2023
Nurse-delivered sleep restriction therapy may be effective for insomnia
Brief, nurse-delivered sleep restriction therapy in primary care reduced insomnia symptoms and appeared cost-effective, an English trial found.
https://immattersacp.org/weekly/archives/2023/08/22/4.htm
22 Aug 2023
Cytisinicline shows promise for smoking cessation in industry-funded trial
In a phase 3 randomized controlled trial, both six- and 12-week courses of cytisinicline, an investigational drug, led to higher rates of continuous smoking abstinence compared with placebo.
https://immattersacp.org/weekly/archives/2023/07/18/1.htm
18 Jul 2023
New blood donor recs; menopause drug approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/07/new-blood-donor-recs-menopause-drug-approved.htm
1 Jul 2023
A living guideline for depression treatment
ACP recommends choosing between a second-generation antidepressant or cognitive behavioral therapy for adults in the acute phase of moderate to severe major depressive disorder.
https://immattersacp.org/archives/2023/06/a-living-guideline-for-depression-treatment.htm
1 Jun 2023
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/06/latest-updates-on-acps-priorities-initiatives.htm
1 Jun 2023
Multiple agents effective for excessive daytime sleepiness but may be discontinued due to side effects, review finds
A systematic review and meta-analysis of 14 trials found that solriamfetol, armodafinil-modafinil, and pitolisant were associated with reduced daytime sleepiness but also with headache, insomnia, and anxiety in patients with obstructive sleep apnea.
https://immattersacp.org/weekly/archives/2023/05/09/1.htm
9 May 2023